Table 3.
Dysfunction assessed | Epilepsy type | Sex (n) | Prevalence | Sexual dysfunction assessment | References |
---|---|---|---|---|---|
Sexual | |||||
i. Global anorgasmia ii. Vaginismus iii. Dyspareunia |
PE | F (99) | i. 17.9% ii. 27.8% iii. 38.5% |
Questionnaire | Morrell and Guldner (1996) |
IGE | F (17) | i. 31.3% ii. 13.3% iii. 18.8% |
|||
i. Sexual arousability ii. Sexual anxiety |
PE | F (99) | i. 72.2% ii. 15.4% |
Questionnaire | Lambert (2001) |
IGE | F (17) | i. 84.2% ii. 7.6% |
|||
Erectile dysfunction | GTCS | M (25) | 72% | Questionnaire | Nikoobakht et al. (2007) |
PE | M (16) | 32% | |||
Erectile dysfunction | PE | M (418) | 25.8% | Clinical interview | Keller et al. (2012) |
IGE | M (166) | 29.5% | |||
Reproductive | |||||
i. Menstrual disorders ii. PCO iii. HA iv. PCOS |
PE | F (90) | i. 44% ii. 46% iii. 33% iv. 44% |
Clinical examination, transvaginal ultrasonography | Löfgren et al. (2007) |
IGE | F (57) | i. 29% ii. 28% iii. 13% iv. 19% |
|||
i. Menstrual disorders ii. Hirsutism iii. PCO |
IGE | F (52) | i. 23% ii. 5.8% iii. 25% |
Clinical examination, transvaginal ultrasonography | Luef et al. (2002a) |
PE | F (40) | i. 42.5% ii. 2.5% iii. 37.5% |
|||
PCO | IGE | F (36) | 21% | Suprapubic ovary ultrasound | Murialdo et al. (1997) |
PE | F (65) | 14.5% | |||
i. Hypomenorrhoea ii. Amenorrhea iii. Oligomenorrhoea iv. Polymenorrhoea |
IGE | F (21) | Overall results i. 22% ii. 16% iii. 9% iv. 2% |
Clinical examination | Demerdash et al. (1991) |
PE | F (106) |
PCO polycystic ovaries, HA hyperandrogenism, PCOS polycystic ovary syndrome, IGE idiopathic generalized epilepsy, PE partial epilepsy, F female